July 18 (Reuters) - Philip Renaud:
* Says acquired 12.5 million units of Kane Biotech in connection with corporation's previously announced non-brokered private placement
* Philip Renaud is chairman and a director of Kane Biotech Inc
* Renaud and entity over which Renaud exercises control now own about 30.56 percent of current issued and outstanding shares of Kane Biotech
* Renaud, entity over which he exercises control have no current intention to acquire ownership/control over additional securities of Kane